Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Cohort Study on Precision Antithrombotic Therapy

NCT07654634 is registered in ClinicalTrials.gov with The Third Xiangya Hospital of Central South University as lead sponsor.

NCT NCT07654634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07654634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Cohort Study on Precision Antithrombotic Therapy
Lead sponsor
The Third Xiangya Hospital of Central South University
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 1, 2026
Completion date
December 31, 2027
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, mi(myocardial infarction), non-valvular atrial fibrillation (nvaf), venous thromboembolism (vte)